Double attack on deadly eye cancer: chemo to liver, drugs to body
NCT ID NCT04283890
Summary
This study is testing a two-part treatment for advanced eye (uveal) melanoma that has spread, mainly to the liver. It combines a liver-targeted chemotherapy procedure with two immunotherapy drugs given into the bloodstream. The goal is to see if this combination can better control cancer both in the liver and elsewhere in the body, and to check how safe it is for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEAL MELANOMA, METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Leiden University Medical Center
Leiden, South Holland, 2333 ZA, Netherlands
Conditions
Explore the condition pages connected to this study.